Literature DB >> 2180706

Clinical manifestations of enterococcal infection.

C M Lewis1, M J Zervos.   

Abstract

Enterococci are important causes of community-acquired and nosocomial infection. They cause endocarditis, bacteremia, urinary tract infections and neonatal sepsis. As causes of intra-abdominal and pelvic infection, enterococci are more commonly associated with abscess, biliary tract infection, spontaneous bacterial peritonitis, post-operative infection, post-partum endomyometritis and chronic or recurrent infection. As causes of soft tissue infection, enterococci are more commonly identified in burns, decubitus or diabetic foot ulcers, and wounds associated with intestinal surgery. Enterococci are often cultured in association with other pathogens when identified in intra-abdominal, pelvic or skin and soft tissue infection. Enterococcal superinfection after therapy with cephalosporins has been well described, and occurs as a result of the low in vitro activity of cephalosporins against enterococci. The epidemiology of enterococcal infection is complex and includes both endogenous and exogenous acquisition of the organism. Antibiotic resistance is an ever-increasing problem complicating therapy in patients with enterococcal infection.

Entities:  

Mesh:

Year:  1990        PMID: 2180706     DOI: 10.1007/BF01963635

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  42 in total

1.  Enterococcal endocarditis. Report of nineteen cases with long-term follow-up data.

Authors:  M G KOENIG; D KAYE
Journal:  N Engl J Med       Date:  1961-02-09       Impact factor: 91.245

2.  The National Occupational Health Survey of Mining.

Authors:  D W Groce; W G Carr; F J Hearl
Journal:  MMWR CDC Surveill Summ       Date:  1986-08

3.  High-level resistance to gentamicin in Streptococcus faecalis: risk factors and evidence for exogenous acquisition of infection.

Authors:  M J Zervos; S Dembinski; T Mikesell; D R Schaberg
Journal:  J Infect Dis       Date:  1986-06       Impact factor: 5.226

4.  Enterococcal superinfection in patients treated with ciprofloxacin.

Authors:  M J Zervos; A E Bacon; J E Patterson; D R Schaberg; C A Kauffman
Journal:  J Antimicrob Chemother       Date:  1988-01       Impact factor: 5.790

5.  Microbial synergy in experimental intra-abdominal abscess.

Authors:  A B Onderdonk; J G Bartlett; T Louie; N Sullivan-Seigler; S L Gorbach
Journal:  Infect Immun       Date:  1976-01       Impact factor: 3.441

6.  Enterococcal bacteremia: clinical implications and determinants of death.

Authors:  R N Garrison; D E Fry; S Berberich; H C Polk
Journal:  Ann Surg       Date:  1982-07       Impact factor: 12.969

7.  Effects of clindamycin and gentamicin and other antimicrobial combinations against enterococci in an experimental model of intra-abdominal abscess.

Authors:  S H Willey; R G Hindes; G M Eliopoulos; R C Moellering
Journal:  Surg Gynecol Obstet       Date:  1989-09

8.  Bacteremia in narcotic addicts at the Detroit Medical Center. II. Infectious endocarditis: a prospective comparative study.

Authors:  D P Levine; L R Crane; M J Zervos
Journal:  Rev Infect Dis       Date:  1986 May-Jun

9.  Enterococcal infections in patients treated with moxalactam.

Authors:  R C Moellering
Journal:  Rev Infect Dis       Date:  1982 Nov-Dec

10.  Enterococcal bacteremia in surgical patients.

Authors:  D T Barrall; P R Kenney; G J Slotman; K W Burchard
Journal:  Arch Surg       Date:  1985-01
View more
  17 in total

Review 1.  Vancomycin-resistant enterococci.

Authors:  Y Cetinkaya; P Falk; C G Mayhall
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

2.  Survival of Enterococcus faecalis in mouse peritoneal macrophages.

Authors:  C R Gentry-Weeks; R Karkhoff-Schweizer; A Pikis; M Estay; J M Keith
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  Production of an endo-beta-N-acetylglucosaminidase activity mediates growth of Enterococcus faecalis on a high-mannose-type glycoprotein.

Authors:  G Roberts; E Tarelli; K A Homer; J Philpott-Howard; D Beighton
Journal:  J Bacteriol       Date:  2000-02       Impact factor: 3.490

4.  Role of Enterococcus faecalis surface protein Esp in the pathogenesis of ascending urinary tract infection.

Authors:  N Shankar; C V Lockatell; A S Baghdayan; C Drachenberg; M S Gilmore; D E Johnson
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

Review 5.  Virulence of enterococci.

Authors:  B D Jett; M M Huycke; M S Gilmore
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

6.  Importance of the aminoglycoside dosing regimen in the penicillin-netilmicin combination for treatment of Enterococcus faecalis-induced experimental endocarditis.

Authors:  B Fantin; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

7.  Vancomycin-resistant gene identification from live bacteria on an integrated microfluidic system by using low temperature lysis and loop-mediated isothermal amplification.

Authors:  Wen-Hsin Chang; Ju-Ching Yu; Sung-Yi Yang; Yi-Cheng Lin; Chih-Hung Wang; Huey-Ling You; Jiunn-Jong Wu; Mel S Lee; Gwo-Bin Lee
Journal:  Biomicrofluidics       Date:  2017-03-02       Impact factor: 2.800

8.  Comparison of Varroa destructor and Worker Honeybee Microbiota Within Hives Indicates Shared Bacteria.

Authors:  Jan Hubert; Martin Kamler; Marta Nesvorna; Ondrej Ledvinka; Jan Kopecky; Tomas Erban
Journal:  Microb Ecol       Date:  2016-04-29       Impact factor: 4.552

9.  Risk factors for acquiring ampicillin-resistant enterococci and clinical outcomes at a Canadian tertiary-care hospital.

Authors:  A E McCarthy; G Victor; K Ramotar; B Toye
Journal:  J Clin Microbiol       Date:  1994-11       Impact factor: 5.948

10.  Typing of Enterococcus species by DNA restriction fragment analysis.

Authors:  L M Hall; B Duke; M Guiney; R Williams
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.